CRE in Companion Animals
af Stephen Cole
1. IncK2
2. Location
2.1. North America
2.2. South America
2.3. Europe
2.4. Asia
2.5. Africa
2.6. Australia
3. Negative Studies
4. Survey of Carbapenemase-Producing Enterobacteriaceae in Companion Dogs in Madrid, Spain (González-Torralba et al., 2016)
5. Enterobacter cloacae Complex Sequence Type 171 Isolates Expressing KPC-4 Carbapenemase Recovered from Canine Patients in Ohio. (Daniels et al., 2018)
6. Plasmids
6.1. IncX3
6.2. IncFIB
6.3. IncHI2
6.4. IncI1-type
6.5. IncFII-type
6.6. IncL
6.7. IncF
6.8. IncL/M-1 type
6.9. IncA/C
6.10. IncI
6.11. IncN
7. Human Involvement
8. Detection of IncN-pST15 One-Health plasmid harboring blaKPC-2 in a hypermucoviscous Klebsiella pneumoniae CG258 isolated from an infected dog, Brazil (Sellera et al., 2021)
9. Emergence of OXA-48 carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in dogs. (Stolle et al., 2013)
10. Molecular Characteristics of NDM-5-Producing Escherichia coli from a Cat and a Dog in South Korea. (Hong et al., 2020)
11. Pathogenic Escherichia coli in Dogs Reveals the Predominance of ST372 and the Human-Associated ST73 Extra-Intestinal Lineages (Valat et al., 2020)
12. Clonal dissemination of OXA-48-producing Enterobacter cloacae isolates from companion animals in Algeria. (Yousfi et al., 2018)
13. Occurrence and characterization of Escherichia coli ST410 co-harbouring blaNDM-5, blaCMY-42 and blaTEM-190 in a dog from the UK (Reynolds et al., 2019)
14. Complete Genome Sequence of a Carbapenem-Resistant Escherichia coli Isolate with blaNDM-5 from a Dog in the United States (Tyson et al., 2019)
15. Distribution and antimicrobial resistance profiles of bacterial species in stray cats, hospital-admitted cats, and veterinary staff in South Korea. (Jung et al., 2020)
16. Additional Resistance
16.1. Colistin
16.2. Sulfonamide
16.3. Fosfomycin
16.4. Aminoglycoside
16.5. Tetracycline
16.6. Quinolone
16.7. Beta-Lactam
16.8. Trimethoprim
16.9. Chloramphenicol
16.10. Macrolide
17. Emergence of a New Delhi metallo-β-lactamase (NDM-1)-encoding gene in clinical Escherichia coli isolates recovered from companion animals in the United States (Shaheen et al., 2013)
18. Antimicrobial susceptibility of bacterial isolates from urinary tract infections in companion animals in Spain. (Darwich et al., 2021)
19. Risk Factors for the Acquisition of a blaNDM-5 Carbapenem-Resistant Escherichia coli in a Veterinary Hospital. (Lavigne et al., 2021)
20. Household transmission of carbapenemase-producing Enterobacteriaceae: a prospective cohort study (Marimuthu et al., 2021)
21. Prevalence of antimicrobial resistance and resistance genes in faecal Escherichia coli isolates recovered from healthy pets (Costa et al., 2008)
22. Beta-Lactamases in Ampicillin-Resistant Escherichia coli Isolates from Foods, Humans, and Healthy Animals (Briñas et al., 2002)
23. Poor infection prevention and control standards are associated with environmental contamination with carbapenemase-producing Enterobacterales and other multidrug-resistant bacteria in Swiss companion animal clinics. (Schmidt et al., 2020)
24. Genomic features of a polymyxin-resistant Klebsiella pneumoniae ST491 isolate co-harbouring blaCTX-M-8 and qnrE1 genes from a hospitalised cat in Sao Paulo, Brazil. (Sartori et al., 2020)
25. Antimicrobial‐resistant Enterobacteriaceae recovered from companion animal and livestock environments (Adams et al., 2018)
26. IncH-type plasmid harboring bla CTX-M-15, bla DHA-1, and qnrB4 genes recovered from animal isolates. (Schluter et al, 2014)
27. Carbapenemase IncF-borne blaNDM-5 gene in the E. coli ST167 high-risk clone from canine clinical infection, Italy. (Alba et al., 2021)
28. Assess acquisition, prevalence of and risk factors for MDRO carriage in dogs and cats presented to veterinary clinics or practices in Switzerland. (Dazio et al., 2021)
29. The occurrence of Salmonella, extended-spectrum β-lactamase producing Escherichia coli and carbapenem resistant non-fermenting Gram-negative bacteria in a backyard poultry flock environment (Shah et al., 2020)
30. Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae Isolated from healthy and sick dogs in Portugal. (Carvalho et al., 2020)
31. Shedding of OXA-181 carbapenemase-producing Escherichia coli from companion animals after hospitalisation in Switzerland: an outbreak in 2018 (Nigg et al., 2019)
32. Colistin Susceptibility in Companion Animal-Derived Escherichia coli, Klebsiella spp., and Enterobacter spp. in Japan: Frequent Isolation of Colistin-Resistant Enterobacter cloacae Complex (Sato et al., 2022)
33. Enterobacterales high-risk clones and plasmids spreading blaESBL/AmpC and blaOXA-48 genes within and between hospitalized dogs and their environment (Haenni et al., 2022)
34. Prevalence, incidence and risk factors for acquisition and colonization of extended-spectrum beta-lactamase- and carbapenemase-producing Enterobacteriaceae from dogs attended at a veterinary hospital in Spain. (Ortiz-Diez et al., 2022)
35. Species Tested
35.1. Dogs
35.1.1. Found Positive
35.1.2. All Negative
35.2. Cats
35.2.1. Found Positive
35.2.2. All Negative
35.3. Other Companion Animals
35.3.1. Found Positive
35.3.2. All Negative